Category,Expression_pattern,gene,Description,Preferred_name,Preferred_name_short
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN984_c4_g1,Interleukin-10 receptor subunit beta,IL10RB receptor for immunosuppressive cytokine ,IL10RB
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN6238_c0_g1,tumor necrosis factor binding,TNFRSF1A,TNFRSF1A
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN3242_c1_g1,fibroblast activation-> IL17 receptor,IL17RA inflammation/antifungal response,IL17RA
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN5500_c0_g1,tumor necrosis factor receptor superfamily member 9,TNFRSF9 survival of CD8+ T cells,TNFRSF9
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN1859_c1_g1,Interferon gamma receptor 2,IFNGR2 intracellular pathogen response,IFNGR2
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN2792_c0_g1,interleukin-17 receptor activity,IL17RE mucosal defense,IL17RE
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN117_c8_g1,Interleukin-4 receptor subunit alpha,IL4R immune suppression/Type 2 response,IL4R
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN2688_c0_g1,Interleukin-20 receptor subunit alpha,IL20RA iflammation,IL20RA
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN13460_c0_g1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,FGFR2 tissue repair,FGFR2
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN1045_c0_g1,Tumor necrosis factor receptor superfamily member,TNFRSF1B TNFa receptor/inflammation,TNFRSF1B
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN15574_c0_g2,interleukin-18 receptor binding,IL18 inflammation ,IL18
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN60227_c0_g1,Interleukin-13 receptor subunit alpha-1,IL13RA1  immune suppression/Type 2 response,IL13RA1
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN35684_c0_g1,transforming growth factor,TGFB1 immune suppression/fibrosis,TGFB1
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN84380_c0_g1,"Interleukin 1, beta",IL1B inflammation ,IL1B
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN6121_c0_g1,Interleukin 17C,IL17C antifungal/sometimes renders susceptible ,IL17C
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN2011_c1_g1,Interleukin-10 family,IL20 inflammation and wound repair,IL20
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN3040_c0_g2,Interleukin-1 / 18,IL18 inflammation,IL18
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN35907_c0_g1,Interleukin-10 family,IL10 immune suppression,IL10
Immune.ligands.and.receptors,Bd.Exposure2,TRINITY_DN15537_c0_g1,Interleukin-1 / 18,IL18 inflammation,IL18
Adaptive.immunity,Bd.Exposure2,TRINITY_DN2630_c1_g1,"Class II histocompatibility antigen, alpha domain",HLA-DMA,HLA-DMA
Adaptive.immunity,Bd.Exposure2,TRINITY_DN95_c2_g1,positive regulation of MHC class I biosynthetic process,CIITA,CIITA
Adaptive.immunity,Bd.Exposure2,TRINITY_DN3022_c0_g2,"HLA class II histocompatibility antigen, DM beta",MHC-DMB,MHC-DMB
Adaptive.immunity,Bd.Exposure2,TRINITY_DN48673_c1_g1,V-set and immunoglobulin,VSIG1 Adhesion molecule,VSIG1
Adaptive.immunity,Bd.Exposure2,TRINITY_DN10812_c3_g1,Sialomucin core protein,CD164 adhesion,CD164
Adaptive.immunity,Bd.Exposure2,TRINITY_DN4958_c1_g1,CD20-like family,MS4A4A macrophage,MS4A4A
Adaptive.immunity,Bd.Exposure2,TRINITY_DN32_c0_g1,Ly-6 antigen / uPA receptor -like domain immune cell  marker,-,LY6
Adaptive.immunity,Bd.Exposure2,TRINITY_DN511_c7_g1,Immunoglobulin,CD58 LFA-3 adhesion,CD58
Adaptive.immunity,Bd.Exposure2,TRINITY_DN36086_c0_g1,"Lectin, galactoside-binding, soluble, 8 immune evasion",LGALS8,LGALS8
Adaptive.immunity,Bd.Exposure2,TRINITY_DN0_c5_g1,OX-2 membrane,CD200,CD200
Adaptive.immunity,Bd.Exposure2,TRINITY_DN2540_c0_g1,thrombin-activated receptor activity,F2RL2,F2RL2
Antimicrobial.responses,Bd.Exposure2,TRINITY_DN1708_c0_g1,"Chymotrypsin-like elastase family, member 1",CELA1,CELA1
Antimicrobial.responses,Bd.Exposure2,TRINITY_DN13_c2_g1,collagen biosynthetic process,TRAM2,TRAM2
Antimicrobial.responses,Bd.Exposure2,TRINITY_DN10667_c0_g1,Interferon-induced transmembrane protein,-,IFITM
Antimicrobial.responses,Bd.Exposure2,TRINITY_DN1125_c4_g1,NADPH oxidase activator 1,NOXA1,NOXA1
Antimicrobial.responses,Bd.Exposure2,TRINITY_DN2128_c0_g1,MDA-5 signaling pathway,IFIH1 antiviral/innnate response,IFIH1
Antimicrobial.responses,Bd.Exposure2,TRINITY_DN2189_c0_g1,platelet formation,NBEAL2,NBEAL2
Antimicrobial.responses,Bd.Exposure2,TRINITY_DN8938_c1_g1,Lipopolysaccharide-induced tumor necrosis factor-alpha factor,LITAF,LITAF
Antimicrobial.responses,Bd.Exposure2,TRINITY_DN518_c12_g1,interleukin-6 secretion,NOS2 Nitric Oxide production,NOS2
Antimicrobial.responses,Bd.Exposure2,TRINITY_DN3777_c0_g1,Cathelicidin antimicrobial peptide,CAMP,CAMP
Antimicrobial.responses,Bd.Exposure2,TRINITY_DN310_c2_g1,"Coagulation factor 5/8 C-terminal domain, discoidin domain",DDR2,DDR2
Antimicrobial.responses,Bd.Exposure2,TRINITY_DN2296_c2_g1,lipopolysaccharide binding,BPI,BPI
Antimicrobial.responses,Bd.Exposure2,TRINITY_DN130_c8_g1,cellular stress response to acidic pH,NOX1,NOX1
Antimicrobial.responses,Bd.Exposure2,TRINITY_DN1280_c1_g1,prostaglandin catabolic process,ABHD16A,ABHD16A
Antimicrobial.responses,Bd.Exposure2,TRINITY_DN17453_c0_g1,regulation of lipid metabolic process,TM6SF2,TM6SF2
Antimicrobial.responses,Bd.Exposure2,TRINITY_DN11103_c0_g1,"Matrix metallopeptidase 3 (stromelysin 1, progelatinase)",MMP3,MMP3
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN10048_c0_g1,Ig-like C2-type domain,IL6ST,IL6ST
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN2205_c0_g1,Interleukin-1 receptor-associated,IRAK2,IRAK2
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN4545_c1_g1,CCR5 chemokine receptor binding,JAK1,JAK1
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN7439_c1_g1,B-1 B cell differentiation,MALT1,MALT1
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN35155_c0_g1,granuloma formation,CEBPB,CEBPB
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN9072_c0_g1,T-helper 1 cell lineage commitment,STAT6,STAT6
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN6014_c0_g1,CD109 molecule,CD109 tgf beta signaling,CD109
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN1854_c1_g1,epithelial cell proliferation,EHF,EHF
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN544_c2_g3,TRAF-interacting protein with,TIFA,TIFA
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN3287_c3_g2,CD40 signaling pathway,RNF31 inflammatory signaling,RNF31
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN1113_c10_g1,lymphoid lineage cell migration into thymus,FOXN1 skin and immune development,FOXN1
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN11659_c0_g1,interferon regulatory factor 7,IRF7,IRF7
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN9476_c1_g1,TRAF3 interacting protein 2,TRAF3IP2,TRAF3IP2
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN259_c12_g1,Signal transducer and activator of transcription,STAT3,STAT3
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN6171_c0_g1,"Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49 p100",NFKB2,NFKB2
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN5442_c0_g1,MAP kinase kinase kinase kinase activity,MAP4K3,MAP4K3
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN1600_c10_g1,factor 10,KLF10,KLF10
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN3347_c1_g1,cysteine-rich with EGF-like,CRELD1 decrase in T cells,CRELD1
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN6956_c2_g2,"Tumor necrosis factor, alpha-induced protein 3",TNFAIP3,TNFAIP3
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN175643_c0_g1,Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,NFKB1,NFKB1
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN36756_c0_g1,regulation of mature B cell apoptotic process,BCL10,BCL10
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN8810_c0_g1,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,IKBKE,IKBKE
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN2544_c1_g1,death-associated protein kinase 2,DAPK2,DAPK2
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN2568_c1_g1,nucleotide-binding oligomerization domain containing 1 signaling pathway,NFKBIA,NFKBIA
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN1709_c0_g1,Tumor necrosis factor alpha-induced protein,TNFAIP2,TNFAIP2
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN3238_c2_g1,death domain binding,TRADD,TRADD
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN4111_c2_g1,Induced myeloid leukemia cell differentiation protein Mcl-1,MCL1,MCL1
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN8514_c0_g2,receptor accessory protein,IL1RAP IL1 siganling/inflammatiopn ,IL1RAP
Immune.cell.signaling,Bd.Exposure2,TRINITY_DN1397_c0_g1,positive regulation of endothelial cell chemotaxis,MET,MET
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN8061_c0_g1,c-X-C motif,CXCL11,CXCL11
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN10924_c0_g1,Programmed cell death 1 ligand 1,CD274 PDL1,CD274
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN34677_c0_g1,Inducible T-cell co-stimulator,ICOS,ICOS
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN33_c8_g1,Interferon alpha beta,IFNAR1,IFNAR1
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN724_c0_g1,cytokine receptor activity,IL21R,IL21R
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN51629_c1_g1,Interleukin 10,IL26 IL17 response by epithelial cells,IL26
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN5135_c0_g1,polymeric immunoglobulin receptor,PIGR transport of mucosla Abs,PIGR
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN91045_c1_g1,CD40 receptor binding,CD40LG,CD40LG
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN11121_c0_g3,regulation of lymphocyte apoptotic process,CD3D,CD3D
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN11320_c0_g1,cell-matrix adhesion involved in ameboidal cell migration,ITGB7,ITGB7
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN8367_c0_g1,CD209 antigen-like protein,CD209,CD209
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN76001_c0_g1,SLAM family member 5,CD84,CD84
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN920_c2_g1,interleukin-2 binding,IL2RG,IL2RG
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN3659_c1_g1,Toll-like receptor,TLR2,TLR2
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN39917_c0_g1,tumor necrosis factor-activated receptor activity,CD40,CD40
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN9332_c0_g1,Interleukin-27 receptor subunit alpha,IL27RA,IL27RA
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN24448_c0_g1,Tumor necrosis factor ligand superfamily member 6,FASLG,FASLG
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN13107_c0_g1,T cell CD4 receptor C terminal region,CD4,CD4
Immune.ligands.and.receptors,Pre.Exposure,TRINITY_DN8303_c0_g1,T-cell surface glycoprotein,CD4,CD4
Adaptive.immunity,Pre.Exposure,TRINITY_DN2206_c1_g1,"Class II histocompatibility antigen, beta domain",HLA-DRB1,HLA-DRB1
Adaptive.immunity,Pre.Exposure,TRINITY_DN3493_c1_g1,positive regulation of interleukin-10 biosynthetic process,BCL3,BCL3
Adaptive.immunity,Pre.Exposure,TRINITY_DN2630_c0_g2,Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system,B2M,B2M
Adaptive.immunity,Pre.Exposure,TRINITY_DN493_c0_g1,Major histocompatibility complex class I-related gene protein-like,MR1,MR1
Adaptive.immunity,Pre.Exposure,TRINITY_DN1360_c1_g1,Major histocompatibility complex class I-related gene protein-like,MR1,MR1
Adaptive.immunity,Pre.Exposure,TRINITY_DN3106_c21_g1,Immunoglobulin C-Type,TRBV25-1,TRBV25-1
Adaptive.immunity,Pre.Exposure,TRINITY_DN93957_c0_g1,TAP binding protein (tapasin),TAPBP,TAPBP
Adaptive.immunity,Pre.Exposure,TRINITY_DN8376_c0_g1,Immunoglobulin C-Type,SIRPB1 IFN induced,SIRPB1
Adaptive.immunity,Pre.Exposure,TRINITY_DN2269_c0_g1,Immunoglobulin omega chain-like,IGLV5-45,IGLV5-45
Adaptive.immunity,Pre.Exposure,TRINITY_DN18964_c0_g1,Major histocompatibility complex class I-related gene protein-like,MR1,MR1
Adaptive.immunity,Pre.Exposure,TRINITY_DN18006_c0_g1,Immunoglobulin V-Type,-,IgV
Adaptive.immunity,Pre.Exposure,TRINITY_DN63073_c0_g1,E3 ubiquitin-protein ligase RNF25,RNF25,RNF25
Adaptive.immunity,Pre.Exposure,TRINITY_DN1731_c0_g1,Proteasome subunit beta type-8,PSMB8,PSMB8
Adaptive.immunity,Pre.Exposure,TRINITY_DN88427_c0_g1,Major histocompatibility complex class I-related gene protein-like,MR1,MR1
Adaptive.immunity,Pre.Exposure,TRINITY_DN3219_c0_g1,peptide antigen-transporting ATPase activity,TAP1,TAP1
Adaptive.immunity,Pre.Exposure,TRINITY_DN23475_c0_g1,"Proteasome (prosome, macropain) subunit, beta type",PSMB9,PSMB9
Adaptive.immunity,Pre.Exposure,TRINITY_DN3472_c0_g1,Immunoglobulin V-Type,-,IgV
Adaptive.immunity,Pre.Exposure,TRINITY_DN3259_c3_g2,"Part of the TCR-CD3 complex present on T-lymphocyte cell surface that plays an essential role in adaptive immune response. When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain. Upon TCR engagement, these motifs become phosphorylated by Src family protein tyrosine kinases LCK and FYN, resulting in the activation of downstream signaling pathways. In addition of this role of signal transduction in T-cell activation, CD3E plays an essential role in correct T-cell development. Initiates the TCR-CD3 complex assembly by forming the two heterodimers CD3D CD3E and CD3G CD3E. Participates also in internalization and cell surface down- regulation of TCR-CD3 complexes via endocytosis sequences present in CD3E cytosolic region",CD3E,CD3E
Antimicrobial.responses,Pre.Exposure,TRINITY_DN3423_c0_g1,Interferon-inducible GTPase,IRGC,IRGC
Antimicrobial.responses,Pre.Exposure,TRINITY_DN7583_c0_g2,regulation of hematopoietic stem cell proliferation,EIF2AK2,EIF2AK2
Antimicrobial.responses,Pre.Exposure,TRINITY_DN3218_c1_g1,GTPase activity,GBP6 innate immunity,GBP6
Antimicrobial.responses,Pre.Exposure,TRINITY_DN5797_c0_g1,superoxide-generating NADPH oxidase activator activity,NOXO1 reactive oxygen production ,NOXO1
Antimicrobial.responses,Pre.Exposure,TRINITY_DN5664_c4_g1,regulation of erythrocyte enucleation,TRIM35,TRIM35
Antimicrobial.responses,Pre.Exposure,TRINITY_DN53191_c0_g1,Interferon-induced transmembrane protein, antiviral,IFITM
Antimicrobial.responses,Pre.Exposure,TRINITY_DN13357_c1_g2,dynamin family protein polymerization involved in membrane fission,MX1 antiviral,MX1
Antimicrobial.responses,Pre.Exposure,TRINITY_DN8923_c1_g1,DEXH (Asp-Glu-X-His) box polypeptide 58,DHX58,DHX58
Antimicrobial.responses,Pre.Exposure,TRINITY_DN8286_c0_g1,Interferon-inducible GTPase,IRGC,IRGC
Antimicrobial.responses,Pre.Exposure,TRINITY_DN4667_c0_g1,Predicted membrane protein (DUF2053),TMEM147,TMEM147
Antimicrobial.responses,Pre.Exposure,TRINITY_DN7972_c2_g1,Stimulator of interferon genes protein,TMEM173,TMEM173
Antimicrobial.responses,Pre.Exposure,TRINITY_DN20322_c0_g1,defense response to virus,IFIT5 antiviral,IFIT5
Antimicrobial.responses,Pre.Exposure,TRINITY_DN107140_c0_g1,Interferon-induced 35 kDa protein (IFP 35) N-terminus,NMI,NMI
Antimicrobial.responses,Pre.Exposure,TRINITY_DN57868_c0_g2,Interferon-inducible double-stranded RNA-dependent protein kinase activator A isoform X1,PRKRA,PRKRA
Antimicrobial.responses,Pre.Exposure,TRINITY_DN150542_c0_g1,ISG15-specific protease activity,USP18 IFN,USP18
Antimicrobial.responses,Pre.Exposure,TRINITY_DN5933_c0_g1,Immunoglobulin C-Type,SIRPB1 IFN response,SIRPB1
Antimicrobial.responses,Pre.Exposure,TRINITY_DN2728_c0_g2,interferon-alpha production,AZI2,AZI2
Antimicrobial.responses,Pre.Exposure,TRINITY_DN4141_c3_g1,RIG-I signaling pathway,DDX58 RIGI antiviral,DDX58
Immune.cell.signaling,Pre.Exposure,TRINITY_DN35925_c0_g1,basic region leucin zipper,BATF3 DC and T cell ,BATF3
Immune.cell.signaling,Pre.Exposure,TRINITY_DN85_c0_g1,positive regulation of interleukin-4-mediated signaling pathway,PARP14,PARP14
Immune.cell.signaling,Pre.Exposure,TRINITY_DN4330_c0_g1,interferon regulatory factor,IRF8,IRF8
Immune.cell.signaling,Pre.Exposure,TRINITY_DN4567_c0_g1,dendritic cell proliferation,TBK1,TBK1
Immune.cell.signaling,Pre.Exposure,TRINITY_DN9944_c0_g1,Lymphocyte activation gene 3 protein,LAG3,LAG3
Immune.cell.signaling,Pre.Exposure,TRINITY_DN10577_c1_g1,interferon regulatory factor,IRF4,IRF4
Immune.cell.signaling,Pre.Exposure,TRINITY_DN7823_c0_g4,myeloid dendritic cell differentiation,BATF2,BATF2
Immune.cell.signaling,Pre.Exposure,TRINITY_DN1620_c0_g2,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,PHF14,PHF14
Immune.cell.signaling,Pre.Exposure,TRINITY_DN10341_c0_g2,positive regulation of peripheral T cell tolerance induction,FOXP3,FOXP3
Immune.cell.signaling,Pre.Exposure,TRINITY_DN6841_c0_g1,Mitogen-activated protein kinase kinase kinase 4,MAP3K4,MAP3K4
Immune.cell.signaling,Pre.Exposure,TRINITY_DN104473_c0_g2,olfactory receptor binding,RTP4,RTP4
Immune.cell.signaling,Pre.Exposure,TRINITY_DN9459_c0_g1,interferon regulatory factor,FOXS1,FOXS1
Immune.cell.signaling,Pre.Exposure,TRINITY_DN26581_c0_g1,Serine threonine-protein kinase LMTK2,LMTK2,LMTK2